Sertindole

Results: 21



#Item
1Cost-effectiveness of Sertindole among atypical antipsychotics in the treatment of schizophrenia in South Korea

Cost-effectiveness of Sertindole among atypical antipsychotics in the treatment of schizophrenia in South Korea

Add to Reading List

Source URL: www.ispor.org

Language: Spanish - Date: 2014-01-16 17:51:12
    2Cost-effectiveness of Sertindole among atypical antipsychotics in the treatment of schizophrenia in South Korea

    Cost-effectiveness of Sertindole among atypical antipsychotics in the treatment of schizophrenia in South Korea

    Add to Reading List

    Source URL: www.ispor.org

    Language: Spanish - Date: 2014-01-16 17:51:12
      3Sertindole USFDA PDAC Core Deck

      Sertindole USFDA PDAC Core Deck

      Add to Reading List

      Source URL: www.fda.gov

      Language: English
      4Sertindole Briefing Materials

      Sertindole Briefing Materials

      Add to Reading List

      Source URL: www.fda.gov

      Language: English
      5Addendum: Review and Evaluation of Clinical Data NDA #20-644

      Addendum: Review and Evaluation of Clinical Data NDA #20-644

      Add to Reading List

      Source URL: www.fda.gov

      Language: English
      6Microsoft PowerPoint - FINAL Back-Up Slides (for FDA).ppt

      Microsoft PowerPoint - FINAL Back-Up Slides (for FDA).ppt

      Add to Reading List

      Source URL: www.fda.gov

      Language: English
      7Advisory Committee Briefing Materials:

      Advisory Committee Briefing Materials:

      Add to Reading List

      Source URL: www.fda.gov

      Language: English
      8HIGHLIGHTS OF PRESCRIBING INFORMATION

      HIGHLIGHTS OF PRESCRIBING INFORMATION

      Add to Reading List

      Source URL: www.fda.gov

      Language: English
      9U.S. Food and Drug Administration  Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

      U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may

      Add to Reading List

      Source URL: www.fda.gov

      Language: English
      10Interdisciplinary Review Team for QT Studies Consultation:  Multiple Ascending Dose (MAD) Study Review IND

      Interdisciplinary Review Team for QT Studies Consultation: Multiple Ascending Dose (MAD) Study Review IND

      Add to Reading List

      Source URL: www.fda.gov

      Language: English